Paul Giannasca, VP of Development at GENOCEA BIOSCIENCES, INC. (GNCA), sold 6,760 shares at $12.86 ($85K) on 2014-08-29, disclosed to the SEC on 2014-08-29.
Open-market sale of $85k GNCA by VP of Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.77 | 1,303 | $17K | 19.7% |
| 2 | $12.36 | 4,602 | $57K | 67.3% |
| 3 | $12.86 | 855 | $11K | 13.0% |
| Total | $12.50 avg | 6,760 | $85K | 100% |